Research - Rockville, Maryland, United States
Halo Therapeutics is developing a clinical stage, orally available anti-fibrotic in diseases of unmet need, including DMD, IPF, Hepatic Fibrosis, and Scleroderma. Halo Therapeutics is currently funded by patient associations representing those disease areas
Amazon CloudFront
Amazon Elastic Load Balancer
Amazon AWS